1. Home
  2. Analysis
  3. Cyanocobalamin
  4. Bupivacaine

Cyanocobalamin and Bupivacaine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 17 people who take Cyanocobalamin and Bupivacaine. Common interactions include fatigue among females, and hydronephrosis among males.

The phase IV clinical study analyzes what interactions people who take Cyanocobalamin and Bupivacaine have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

17 people who take Cyanocobalamin and Bupivacaine together, and have interactions are studied.

What is Cyanocobalamin?

Cyanocobalamin has active ingredients of cyanocobalamin. It is used in vitamin b12 deficiency. Currently, eHealthMe is studying from 11,327 Cyanocobalamin users.

What is Bupivacaine?

Bupivacaine has active ingredients of bupivacaine hydrochloride. Currently, eHealthMe is studying from 13,315 Bupivacaine users.

Number of Cyanocobalamin and Bupivacaine reports submitted per year:

Cyanocobalamin and Bupivacaine drug interactions.

Common Cyanocobalamin and Bupivacaine drug interactions by gender *:

female:

  1. Fatigue
  2. Vomiting
  3. Abdominal discomfort
  4. Alopecia
  5. Blood cholesterol increased
  6. C-reactive protein increased
  7. Decreased appetite
  8. Dizziness
  9. Drug ineffective
  10. Drug intolerance

male:

  1. Hydronephrosis
  2. Leukopenia
  3. Lymphocele
  4. Ureteric stenosis
  5. Cystitis
  6. Disease progression
  7. Fatigue
  8. Pruritus
  9. Urinary tract infection

Common Cyanocobalamin and Bupivacaine drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cystitis
  2. Urinary tract infection

40-49:

  1. Hydronephrosis
  2. Leukopenia
  3. Lymphocele
  4. Ureteric stenosis
  5. Fistula

50-59:

n/a

60+:

  1. Anaesthetic complication neurological
  2. Arthralgia
  3. White blood cell count decreased
  4. Arthritis bacterial
  5. Encephalopathy
  6. Fatigue
  7. Listeria sepsis
  8. Meningeal neoplasm
  9. Meningitis listeria
  10. Nausea

Common conditions people have *:

  1. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract): 7 people, 41.18%
  2. High Blood Pressure: 5 people, 29.41%
  3. Indigestion: 4 people, 23.53%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 23.53%
  5. Nausea And Vomiting: 4 people, 23.53%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 23.53%
  7. Abdominal Infection: 3 people, 17.65%
  8. Diabetes: 3 people, 17.65%
  9. Infection: 3 people, 17.65%
  10. Menopause (end of monthly cycles in women): 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Cyanocobalamin and Bupivacaine?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Cyanocobalamin drug interactions:

Browse interactions between Cyanocobalamin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Bupivacaine drug interactions:

Browse interactions between Bupivacaine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cyanocobalamin and bupivacaine hydrochloride (the active ingredients of Cyanocobalamin and Bupivacaine, respectively), and Cyanocobalamin and Bupivacaine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Cyanocobalamin and Bupivacaine.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.